Use of melphalan, thalidomide, and dexamethasone in treatment of refractory and relapsed multiple myeloma

By Srkalovic Gordan   Elson Paul   Trebisky Beth   Karam Mary   Hussein Mohamad  

Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. : 219-226

Humana Press, Inc

Access to resources Recommend Favorite

Management Strategies for Relapsed Multiple Myeloma

By Richardson Paul G.   Schlossman Robert   Munshi Nikhil   Anderson Kenneth  

American Journal of Cancer, Vol. 5, Iss. 6, 2006-01 ,pp. : 393-409

Adis International

Access to resources Recommend Favorite

Intravenous injection of bortezomib, melphalan and dexamethasone in refractory and relapsed multiple myeloma

By Romano A.   Chiarenza A.   Consoli U.   Conticello C.   Forte S.   Uccello G.   Vetro C.   Cavalli M.   Coppolino F.   Palumbo G. A.   Di Raimondo F.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1038-1044

Oxford University Press

Access to resources Recommend Favorite

Proteasome inhibitors in the treatment of multiple myeloma

By McBride Ali   Ryan Patricia Y  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. : 339-358

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Multiple Myeloma: Current Management and New Approaches

By Ho P.J.   Gibson J.   Joshua D.E.  

American Journal of Cancer, Vol. 3, Iss. 1, 2004-01 ,pp. : 47-66

Adis International

Access to resources Recommend Favorite